Cercar
01/03/2026
Clinical and Economic Implications of Immunoglobulin Use Under Restrictive Conditions in Adult Patients With Neurological Diseases and Immunodeficiencies in Spain
Querol, L, Montoro-Ronsano, JB, Soler-Palacín, P, Galduf, J, Martínez-Pérez, O, Díaz-Cuervo, H. Clinical and Economic Implications of Immunoglobulin Use Under Restrictive Conditions in Adult Patients With Neurological Diseases and Immunodeficiencies in Spain. EUROPEAN JOURNAL OF NEUROLOGY. 2026; 33(3)DOI:10.1111/ene.70570. PMID:41834317. IF:3.900(Q1/3D).
28/04/2026
Failure of early B cell tolerance and possible BCR signaling dysregulation underlie NF155-mediated autoimmune nodopathies
Roy, B, Obaid, AH, Wang, ZJ, Kovacs, KG, Ohashi, S, Kalayci, FNC, Joo, D, Masi, G, Coppola, C, Das, S, Hernandez, AL, Martin-Aguilar, L, Lleixà, C, Nowak, RJ, Querol, L, O'Connor, KC. Failure of early B cell tolerance and possible BCR signaling dysregulation underlie NF155-mediated autoimmune nodopathies. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2026; 123(17)DOI:10.1073/pnas.2525717123. PMID:42008666. IF:9.100(Q1/2D).
01/04/2026
Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease
Bermejo-Guerrero, L, Restrepo-Vera, JL, Martin-Jimenez, P, Navarro-Riquelme, M, Garrido-Moraga, R, Ochoa, LE, González-Quintana, A, Hernandez-Lain, A, Castillo-Villalba, J, Morís, G, Muelas, N, García-Arumí, E, González, V, Martínez-Sáez, E, Vesperinas, A, Llansó, L, Juntas-Morales, R, Paradas, C, Kapetanovic, S, Blázquez, A, Martí, R, Arenas, J, Martín, MA, Domínguez-González, C. Clinical Heterogeneity and Candidate Biomarkers in POLG-Related Mitochondrial Disease. Neurology-Genetics. 2026; 12(2)DOI:10.1212/NXG.0000000000200365. PMID:41822038. IF:3.700(Q1/3D).
09/03/2026
Gait analysis reveals new outcome measures for monitoring disease progression in individuals with late-onset Pompe disease
Claramunt-Molet, M, Pegueroles, J, Pi-Cervera, A, Rico, M, Idelsohn-Zielonka, S, Domínguez-González, C, Corti, M, Antón, V, Salabarria, SM, Wong, K, James, MK, Byrne, BJ, Díaz-Manera, J. Gait analysis reveals new outcome measures for monitoring disease progression in individuals with late-onset Pompe disease. Journal of NeuroEngineering and Rehabilitation. 2026; 23(1)DOI:10.1186/s12984-026-01898-8. PMID:41803906. IF:5.200(Q1/1D).
20/04/2026
Connecting HTT intermediate alleles and microRNA dysregulation to enhanced tauopathy in late-onset Alzheimer's disease
Castilla-Silgado, J, Perez-Oliveira, S, Pinto-Hernandez, P, Fernandez-Sanjurjo, M, Corte-Torres, MD, Fernandez-Alvarez, O, Iglesias-Gutierrez, E, Menendez-Gonzalez, M, Alvarez, V, Tomas-Zapico, C. Connecting HTT intermediate alleles and microRNA dysregulation to enhanced tauopathy in late-onset Alzheimer's disease. Alzheimers Research & Therapy. 2026; 18(1)DOI:10.1186/s13195-026-02039-y. PMID:42010634. IF:7.600(Q1/1D).
01/04/2026
Myasthenia gravis in Spain: A survey of specialized neurologists to uncover unmet needs
Cortés-Vicente, E, Casasnovas, C, Juntas, R, Sevilla, T, Pardo, J, de Rivera, FR, Sola, AG. Myasthenia gravis in Spain: A survey of specialized neurologists to uncover unmet needs. NEUROLOGIA. 2026; 41(3)DOI:10.1016/j.nrl.2025.501912. PMID:. IF:3.100(Q2/4D).
14/03/2024
Cognitive disorders in advanced Parkinson's disease: challenges in the diagnosis of delirium
Daniels, C, Rodriguez-Antigueedad, J, Jentschke, E, Kulisevsky, J, Volkmann, J. Cognitive disorders in advanced Parkinson's disease: challenges in the diagnosis of delirium. Neurological Research And Practice. 2024; 6(1)DOI:10.1186/s42466-024-00309-4. PMID:38481336. IF:(Q/D).
01/10/2022
Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium
Sexton, C, Solis, M, Aharon-Peretz, J, Alexopoulos, P, Apostolova, LG, Bayen, E, Birkenhager, B, Cappa, S, Constantinidou, F, Fortea, J, Gerritsen, DL, Hassanin, HI, Ibanez, A, Ioannidis, P, Karageorgiou, E, Korczyn, A, Leroi, I, Lichtwarck, B, Logroscino, G, Lynch, C, Mecocci, P, Molinuevo, JL, Papatriantafyllou, J, Papegeorgiou, S, Politis, A, Raman, R, Ritchie, K, Sanchez-Juan, P, Sano, M, Scarmeas, N, Spiru, L, Stathi, A, Tsolaki, M, Yener, G, Zaganas, I, Zygouris, S, Carrillo, M. Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium. ALZHEIMERS & DEMENTIA. 2022; 18(10)DOI:10.1002/alz.12588. PMID:35184367. IF:14.000(Q1/1D).
03/08/2024
Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice
Verberk, IMW, Jutte, J, Kingma, MY, Vigneswaran, S, Gouda, MMTEE, van Engelen, MP, Alcolea, D, Arranz, J, Fortea, J, Lleó, A, Chevalier, C, Marizzoni, M, van de Giessen, EM, Lemstra, AW, Pijnenburg, YAL, van der Flier, WM, den Braber, A, Wilson, D, Schut, MC, van Harten, AC, Teunissen, CE. Development of thresholds and a visualization tool for use of a blood test in routine clinical dementia practice. ALZHEIMERS & DEMENTIA. 2024; 20(9)DOI:10.1002/alz.14088. PMID:39096164. IF:11.100(Q1/1D).
20/03/2024
Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium
Larsen, FK, Baksh, RA, Mcglinchey, E, Langballe, EM, Benejam, B, Beresford-Webb, J, Mccarron, M, Coppus, A, Falquero, S, Fortea, J, Levin, J, Loosli, SV, Mark, R, Rebillat, AS, Zaman, S, Strydom, A. Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium. ALZHEIMERS & DEMENTIA. 2024; 20(5)DOI:10.1002/alz.13779. PMID:38506627. IF:11.100(Q1/1D).
01/01/2024
Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry
Lugogo, NL, Heffler, E, Plaza, V, Hilberg, O, Xia, CM, Nash, S, Pandit, N, Jacob-Nara, JA, Sacks, HJ, Rowe, PJ, Deniz, Y, Hardin, M, Soler, X. Baseline Systemic Oral Corticosteroid Use in Patients with Asthma Initiating Dupilumab Treatment in the Real World: From the RAPID Global Registry. Journal of Asthma and Allergy. 2024; 17DOI:10.2147/JAA.S451689. PMID:38860029. IF:3.000(Q2/4D).
02/01/2024
Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis
Nomah, DK, Díaz, Y, Bruguera, A, Moreno-Fornés, S, Aceiton, J, Reyes-Urueña, J, Llibre, JM, Falcó, V, Imaz, A, Fanjul, FJ, Peraire, J, Deig, E, Domingo, P, Inciarte, A, Casabona, J, Miró, JM. Disparities in Coronavirus Disease 2019 Clinical Outcomes and Vaccination Coverage Among Migrants With Human Immunodeficiency Virus in the PISCIS Cohort: A Population-Based Propensity Score-Matched Analysis. Open Forum Infectious Diseases. 2024; 11(1)DOI:10.1093/ofid/ofad693. PMID:38221982. IF:3.800(Q1/3D).
04/12/2025
BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes
Johnatty, SE, Tudini, E, Parsons, MT, Michailidou, K, Zanti, M, Canson, DM, Davidson, AL, Berger, T, Rosti, RO, Kratz, CP, Kalb, R, McReynolds, LJ, Giri, N, Richardson, ME, Pesaran, T, Surrallés, J, Pujol, R, Vundinti, BR, George, M, Maxwell, KN, Nathanson, K, Domchek, S, Fiesco-Roa, MO, Frias, S, Garcia-de-Teresa, B, Jongmans, M, Lalani, S, Maiburg, M, Prescott, K, Robinson, R, Rajagopalan, S, Blok, LS, Temple, SEL, Tucker, K, Auerbach, AD, Cancio, MI, Kennedy, JA, MacMillan, ML, Tryon, R, Wagner, JE, Walsh, M, Boddicker, NJ, Hu, CL, Weitzel, JN, Dingemans, AJM, Hadler, J, Rotenberg, N, Ramadane-Morchadi, L, de la Hoya, M, James, P, Hansen, TV, Vreeswijk, MPG, Walker, LC, Sharan, SK, Easton, DF, Couch, F, Smogorzewska, A, Nelson, A, Ngeow, J, Tischkowitz, M, Gomez-Garcia, E, Spurdle, AB. BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes. AMERICAN JOURNAL OF HUMAN GENETICS. 2025; 112(12)DOI:10.1016/j.ajhg.2025.10.007. PMID:41172994. IF:8.100(Q1/1D).
01/08/2025
Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study
García-Alfonso, P, Jimenez-Fonseca, P, Soto-Alsar, J, Baraibar, I, Santos, C, La Casta, A, Ghanem, I, Cortijo, G, Méndez, A, Pazo-Cid, R, Vera, R, Melián, M, Alcaide, J, Graña, B, Páez, D, Gallego, I, Lobo, M, Borregón, M, Montes, A, de Castro, E, Carmona-Bayonas, A, Aranda, E. Three-year survival follow-up of patients with gastrointestinal cancer treated during the COVID-19 pandemic in Spain: data from the PANDORA-TTD20 study. ONCOLOGIST. 2025; 30(8)DOI:10.1093/oncolo/oyae300. PMID:39550209. IF:4.200(Q2/3D).
01/12/2024
Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial
García-Alfonso, P, Elez, E, Soto-Alsar, J, Páez, D, Fernández-Montes, A, Graña, B, Salud, A, Yubero, A, Gómez-España, MA, Macías, I, Quintero, G, López-López, C, Fernández-Rodríguez, T, Grávalos, C, González-Flores, E, Guix, M, Paredes, BG, Reina, JJ, Mowbray, JRR, Sastre, J, Aranda, E. Maintenance with 5-FU/LV-aflibercept after induction with FOLFIRI-aflibercept versus FOLFIRI-aflibercept until progression as second-line treatment in older adults with metastatic colorectal cancer: the AFEMA phase II randomized trial. ESMO Open. 2024; 9(12)DOI:10.1016/j.esmoop.2024.103986. PMID:39608305. IF:8.300(Q1/2D).
21/04/2024
Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRI
Aranha, MR, Montal, V, van den Brink, H, Pegueroles, J, Carmona-Iragui, M, Videla, L, Blesa, LM, Benejam, B, Arranz, J, Valldeneu, S, Barroeta, I, Fernández, S, Ribas, L, Alcolea, D, González-Ortiz, S, Bargalló, N, Biessels, GJ, Blesa, R, Lleó, A, Coutinho, AM, Leite, CC, Bejanin, A, Fortea, J. Cortical microinfarcts in adults with Down syndrome assessed with 3T-MRI. ALZHEIMERS & DEMENTIA. 2024; 20(6)DOI:10.1002/alz.13797. PMID:38644660. IF:11.100(Q1/1D).
01/08/2024
Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations
Muñoz-Casares, FC, Martín-Broto, J, Cascales-Campos, P, Torres-Melero, J, López-Rojo, I, Gómez-Barbadillo, J, González-Bayón, L, Sebio, A, Serrano, C, Carvalhal, S, de Souza, JA, Souza, A, Flores-Ayala, G, Fuenmayor, LJP, Lopes-Bras, R, González-López, JA, Vasques, H, Asencio-Pascual, JM. Ibero-American Consensus for the Management of Peritoneal Sarcomatosis: Updated Review and Clinical Recommendations. Cancers. 2024; 16(15)DOI:10.3390/cancers16152646. PMID:39123374. IF:4.400(Q2/3D).
01/03/2026
Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT
Schmidt-Hieber, M, Ljungman, P, Gilbert, P, Knelange, N, Drozd-Sokolowska, J, Basak, G, Einsele, H, Tridello, G, Abdeljelil, NB, Kulagin, A, Balaguer-Rosello, A, Metafuni, E, Faraci, M, Gozdzik, J, Martino, R, Raiola, AM, Xhaard, A, Kuskonmaz, B, Biffi, A, Czyzewski, K, Gabriel, MA, Martínez-Lopez, J, Zaidman, I, Schlegel, PG, Gruhn, B, Krivan, G, Vicent, MG, Mikulska, M, Peric, Z, Averbuch, D, Styczynski, J, Penack, O, de la Camara, R. Central nervous system disorders following haematopoietic stem cell transplantation: a prospective case-control observational study from the Infectious Diseases Working Party and the Transplant Complications Working Party of EBMT. Eclinicalmedicine. 2026; 93DOI:10.1016/j.eclinm.2026.103792. PMID:41783087. IF:10.000(Q1/1D).
01/02/2026
Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations
Döhner, H, Schuh, AC, Recher, C, O'Nions, J, Aldoss, I, Piérola, AA, Allred, AJ, Alonso-Dominguez, JM, Barreyro, L, Bories, P, Daskalakis, N, Della Porta, MG, D'Souza, A, Dugan, J, Esteve, J, Fathi, AT, Ferrante, L, Gaj, S, Garciaz, S, Diaz, AG, Salamero, O, Guttke, C, Gyan, E, Hiebert, B, Jabbour, E, Jentzsch, M, Kantarjian, HM, Konopleva, M, Krönke, J, Hütter-Krönke, ML, Loefgren, C, Lomas, O, Mancini, V, Mantzaris, I, Morillo, D, Packman, K, Papayannidis, C, Philippar, U, Platzbecker, U, Paniagua, SG, Sackey, N, Sauer, T, Shastri, PN, Searle, E, Tovar, N, Trancucci, D, Vallet, N, Vaughan, L, Vyas, P, Wei, AH, Rölling, C. Bleximenib in Combination with Intensive Chemotherapy: A phase 1b Study in Patients with Newly Diagnosed Acute Myeloid Leukemia with KMT2A or NPM1 Alterations. Transplantation And Cellular Therapy. 2026; 32(2)DOI:. PMID:. IF:4.400(Q1/1D).
24/03/2026
Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups
Rivera-Pérez, C, Morgades, M, Alonso-Saladrigues, A, Montesinos, P, Murciano, T, Gil, C, Adán, R, Esteve, J, Fuentes, C, Amigo, ML, González-Martínez, B, Coll, R, Dapena, JL, De Llano, MPQ, Fuster, JL, García-Cadenas, I, Tasso, M, Barba, P, Rives, S, Ribera, JM. Outcomes of pediatric and adult patients with relapsed/refractory cortical (CD1a+) T-cell acute lymphoblastic leukemia. The Spanish experience from SEHOP and PETHEMA groups. ANNALS OF HEMATOLOGY. 2026; 105(4)DOI:10.1007/s00277-026-06956-8. PMID:41874722. IF:2.400(Q2/5D).